作者: D. Krex , B. Klink , C. Hartmann , A. von Deimling , T. Pietsch
DOI: 10.1093/BRAIN/AWM204
关键词: O-6-methylguanine-DNA methyltransferase 、 Long term survival 、 Central nervous system disease 、 Glioblastoma 、 Surgery 、 Young age 、 Oncology 、 Glioma 、 Internal medicine 、 Molecular analysis 、 Primary Glioblastoma 、 Medicine
摘要: The median survival of glioblastoma patients is ∼12 months. However, 3–5% of the patients survives for more than 3 years and are referred to as long-term survivors. The clinical and …